Login

CEO Jessica Skon Highlights BTS Group's Record Quarter in Discussion with Equity Analyst Rikard Engberg | Jessica Skon - CEO of BTS group 00:10:00

Share On Facebook Share On Twitter

Jessica Skon is the President & CEO, BTS Group

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
India's Economic Resilience Amidst Global Challenges
00:10:00
Telekom Malaysia Berhad (TM) through TM Research & Development (TM R&D) wins the AI – Telecommunications Award for innovation.
00:10:00
Business Beyond the Game|Rudy Cline-Thomas,Co-Founder and General Partner,Mastry
00:10:00
Understanding Private Equity: What Investors Need to Know
00:10:00
Harold Boël on Sofina's Long-term Investment Strategy | Harold Boël, CEO, Sofina.
00:10:00
Achieving Financial Freedom: Key Steps and Insights from the Wise Money Show
00:10:00
PYX Resources' Export License and Its Role in Strengthening EBITDA | Oliver Hasler, CEO , PYX Resources Ltd.
00:10:00
Brad Katsuyama, CEO of IEX, discusses Interactive Brokers' transition to IEX in a CNBC segment.
00:10:00
Nickel Industry Faces Production Cuts and Environmental Challenges Amid Low Price
00:10:00
Insights into Mexico's Fibra Market: A Conversation with Miguel Aliaga, CFO of Fibra Inn|Managing Director,Acadia Realty Trust
00:10:00
Amprius CEO Dr. Kang Sun and Jon Bornstein discuss high-throughput microfabrication and the silicon solution in Episode 16 of Nano Ops Inc.|Dr. Sun has also served as President, Chief Executive Officer and a director of Amprius, Inc
00:00:00
Identifying High Mortality Risk in Moderate Aortic Stenosis - Dr. Chieh-Ju Chao, Cardiologist, Mayo Clinic

© 2017 - Neuhu+